1. Home
  2. AVLN vs PSNY Comparison

AVLN vs PSNY Comparison

Compare AVLN & PSNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avalyn Pharma Inc. Common Stock

AVLN

Avalyn Pharma Inc. Common Stock

N/A

Current Price

$27.52

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Logo Polestar Automotive Holding UK PLC ADS

PSNY

Polestar Automotive Holding UK PLC ADS

N/A

Current Price

$6.27

Market Cap

1.3B

ML Signal

N/A

Company Overview

Basic Information
Metric
AVLN
PSNY
Founded
2011
2017
Country
United States
Sweden
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2026
2021

Fundamental Metrics

Financial Performance
Metric
AVLN
PSNY
Price
$27.52
$6.27
Analyst Decision
Strong Buy
Sell
Analyst Count
4
3
Target Price
★ $62.25
$12.50
AVG Volume (30 Days)
192.8K
★ 291.6K
Earning Date
08-12-2026
09-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$3.84
Revenue Next Year
N/A
$35.40
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.90
$0.50
52 Week High
$40.17
$23.75

Technical Indicators

Market Signals
Indicator
AVLN
PSNY
Relative Strength Index (RSI) 35.91 20.44
Support Level $25.86 N/A
Resistance Level $30.45 $8.15
Average True Range (ATR) 2.25 0.38
MACD -0.56 0.10
Stochastic Oscillator 14.12 0.81

Price Performance

Historical Comparison
AVLN
PSNY

About AVLN Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.

About PSNY Polestar Automotive Holding UK PLC ADS

Polestar Automotive Holding UK PLC is a pure play, premium electric car brand, designing performance cars engineered to excite consumers and drive change. It believes that it defines market standards in design, innovation and sustainability. It is determined to improve society by accelerating the shift to sustainable mobility. The company conducts its business as one operating segment with primary commercial operations in Europe, North America, Asia Pacific and various importer markets. The company generates majority of revenue from United Kingdom.

Share on Social Networks: